lane_number,tumor_level_prostate,cigarettes_per_day,cases,alcohol_intensity,transcript,gleason_grade_group,imaging_date,center_type,submitted_genomic_profiles,cause_of_death_source,short_name,sequencing_center,iss_stage,enneking_msts_grade,body_surface_area,days_to_recurrence,molecular_tests,nadir_cd4_count,pairs_on_diff_chr
1,Peripheral zone,0,Breast cancer,Drinker,ENST00000367770.8,Group 1,2023-01-15,Comprehensive Cancer Center (CCC),BRCA1_mutation_profile,Autopsy,MDACC,Broad Institute,I,High Grade (G2),1.52,45,BRCA1/2 mutation analysis,15,120
2,Transitional zone,1,Lung cancer,Heavy Drinker,NM_007294.4,Group 2,2023-02-20,Basic Research Center (BRC),TP53_variant_analysis,Death Certificate,DFCI,Genentech,II,Low Grade (G1),1.63,90,EGFR mutation test,32,450
3,Central zone,5,Prostate cancer,Lifelong Non-Drinker,NM_000546.6,Group 3,2023-03-10,Clinical Research Center (CRC),EGFR_exon_19_deletions,Medical Record,MSKCC,Illumina Clinical Services Laboratory,III,Not Reported,1.74,120,ALK gene rearrangements,50,75
4,Anterior fibromuscular stroma,10,Colorectal cancer,Non-Drinker,NM_005157.5,Group 4,2023-04-05,Cancer Prevention Center (CPC),KRAS_G12C_mutation_detection,Not Reported,JHH,National Cancer Institute,Not Reported,Unknown,1.85,180,PD-L1 expression,72,300
5,Periurethral zone,15,Melanoma,Not Reported,ENST00000269305.10,Group 5,2023-05-25,Pediatric Cancer Center (PCC),ALK_rearrangement_characterization,Social Security Death Index,UCLA,MD Anderson Cancer Center,Unknown,Not Reported,1.95,210,KRAS mutation test,88,180
6,Apex,20,Leukemia,Occasional Drinker,NM_004333.5,Not Reported,2023-06-30,Community Cancer Center (ComCC),HER2_amplification_status,Unknown,UCSF,Mayo Clinic Genomics Core,II,Not Reported,2.06,270,HER2/neu amplification,105,600
7,Base,25,Lymphoma,Social Drinker,NM_002524.5,Group 2,2023-07-15,National Cancer Institute (NCI),PIK3CA_mutation_spectrum,Not Reported,MGH,Memorial Sloan Kettering Cancer Center,Not Reported,Unknown,2.17,365,PIK3CA mutation analysis,123,90
8,Mid gland,30,Bladder cancer,Unknown,ENST00000445888.7,Group 2,2023-08-09,Integrated Cancer Center (ICC),PD-L1_expression_quantification,Autopsy,NCI,Wellcome Sanger Institute,Not Reported,Not Reported,2.28,400,MSI testing (Microsatellite Instability),145,240
9,Anterior horn,40,Pancreatic cancer,Unknown,NM_000059.4,Group 4,2023-09-22,Regional Cancer Center (RCC),NTRK_gene_fusion_identification,Death Certificate,FHCRC,Beijing Genomics Institute,Unknown,Not Reported,2.39,500,TMB testing (Tumor Mutational Burden),167,330
10,Posterior horn,50,Kidney cancer,Non-Drinker,NM_004360.4,Group 2,2023-10-13,Cancer Treatment Center (CTC),MMR_deficiency_profile,Death Certificate,SCCA,European Molecular Biology Laboratory,Unknown,Not Reported,2.5,600,NTRK gene fusion,190,210
11,Lateral horn,60,Thyroid cancer,Non-Drinker,NM_001005862.3,Group 2,2023-11-03,Molecular Oncology Center (MOC),CDKN2A_loss_of_function_analysis,Unknown,BWH,Johns Hopkins Genomic Core Facility,III,Unknown,2.61,730,BCR-ABL fusion protein,210,150
12,Medial horn,70,Ovarian cancer,Not Reported,ENST00000557334.5,Group 1,2023-12-01,Cancer Immunotherapy Center (CIC),BCR-ABL_translocation_typing,Medical Record,UPMC,Dana-Farber Cancer Institute,Unknown,Not Reported,2.72,800,CD20 expression,230,270
13,Superior aspect,80,Liver cancer,Social Drinker,NM_000314.6,Group 4,2024-01-20,Genomic Medicine Center (GMC),MET_exon_14_skipping_variants,Death Certificate,CSHL,The Francis Crick Institute,Unknown,Not Reported,2.83,900,FLT3 mutations,255,360
14,Inferior aspect,90,Cervical cancer,Lifelong Non-Drinker,NM_001256849.2,Group 4,2024-02-17,Radiation Oncology Center (ROC),VHL_gene_mutation_assessment,Not Reported,LCI,Cold Spring Harbor Laboratory,Not Reported,Not Reported,2.94,1000,IDH1/2 mutation analysis,280,420
15,Parietal lobe,100,Esophageal cancer,Heavy Drinker,NM_017617.3,Group 2,2024-03-12,Surgical Oncology Center (SOC),IDH1_R132H_mutation_detection,Unknown,VCCC,HudsonAlpha Institute for Biotechnology,Unknown,Not Reported,3.05,1100,MGMT promoter methylation,305,30
